In this scenario, orthotopic transplants in syngeneic wild type adult mice of mPrOs (Cambuli et al, 2022) carrying tumor-associated Foxa1 mutations will provide a valuable preclinical platform to test the efficacy of RA signaling in counteracting the tumorigenic process according to the specific class of Foxa1 mutations. This evidence concerns the gene FOXA1 and neoplasm.